iSpecimen Inc.

NasdaqCM ISPC

iSpecimen Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 10.39 M

iSpecimen Inc. Revenue is USD 10.39 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.74% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • iSpecimen Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 10.31 M, a 3.25% change year over year.
  • iSpecimen Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 9.99 M, a -11.63% change year over year.
  • iSpecimen Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 11.30 M, a 67.30% change year over year.
  • iSpecimen Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 6.76 M.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NasdaqCM: ISPC

iSpecimen Inc.

CEO Ms. Leslie Hoyt
IPO Date June 17, 2021
Location United States
Headquarters 450 Bedford Street
Employees 53
Sector Health Care
Industries
Description

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Similar companies

XGN

Exagen Inc.

USD 3.00

-3.85%

PSNL

Personalis, Inc.

USD 5.13

-4.11%

FONR

FONAR Corporation

USD 15.16

0.20%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

OCX

OncoCyte Corporation

USD 2.15

3.36%

INBS

Intelligent Bio Solutions Inc.

USD 1.30

-1.52%

StockViz Staff

January 15, 2025

Any question? Send us an email